Earnings Call · Q2 FY2021·2021-08-12

Q2 21EPS +8.70%·Rev n/aQ1 21EPS 0.00%·Rev n/aQ4 20EPS -5.00%·Rev n/aQ3 20EPS -11.11%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

AJ Bergmann — Chief Financial Officer

Linda Marbán — Chief Executive Officer

+1.6%1d on move date+1.3% vs SPY3d−8.8%5d−10.9%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access